Left atrial appendage closure using the amulet device: An initial experience with the second generation amplatzer cardiac plug

Abstract

The Amulet device, which has new novel features as compared with the first generation ACP, is a feasible option for LAA closure. From our initial experience, implantation of the Amulet is associated with high success rate and good short-term outcome.

Left Atrial Appendage Closure With the New Occlutech® Device: First in Man Experience and Neurological Outcome

“…Lam et al . detected 2 leaks <2 mm, which are likely clinically irrelevant using the second generation Amplatzer TM cardiac plug . Two patients in our study presented a thrombus at the device.…”

Twelve-month follow-up of left atrial appendage occlusion with Amplatzer Amulet

“…These series with 17 [7], 20 [8], 24 [9] and 50 [10] patients reported 100%, 100%, 96% and 94% procedural process. The Amulet observational study with 1,073 patients reported 98.8% implant success [14].…”

“…First series of LAAO with the Amplatzer Amulet showed similar procedural and short-term clinical outcomes compared with the ACP [7][8][9][10]. In the series of Abualsaud et al [11] with 50 patients the Amulet was associated with a significant reduction in residual leaks at follow-up.…”

The Watchman FLX – a new device for left atrial appendage occlusion – design, potential benefits and first clinical experience

“…The Watchman FLX can be partially recaptured into the access sheath, re-maneuvered and repositioned either proximally, like the previous generation device, or advanced distally several times before device release due to atraumatic closed distal end using the “ball technique” which helps to find the ideal placement – this technique, quite new for Watchman operators, is well known for Amplatzer Cardiac Plug and Amplatzer Amulet left atrial appendage occluder (St. Jude Medical) implanters [6]. Full recapture is also allowed at every stage of the procedure before the final release of the device.…”